Carmex Cold Sore Treatment named 2015 'Product of the Year'
Franklin, Wis. — Carma Laboratories on Wednesday announced that its new Carmex Cold Sore Treatment has been named the 2015 “Product of the Year” winner in the Specialty Skin Treatment category by Product of the Year USA — the nation’s largest consumer survey on product innovation.
The “Product of the Year” award is backed by the votes of more than 40,000 consumers. For manufacturers of the winning products, the award is a powerful marketing tool that has shown to increase product trial, awareness, distribution and sales. Over the past 25 years, winners across the globe have reported an average sales increase of 10% to 15%. Furthermore, leading global research company TNS recently conducted a study with U.S. shoppers and found that:
“Product of the Year” USA winners outperform category sales performance by 38.1%;
The “Product of the Year” logo is more effective on a package than the word “NEW”; and
Coupon redemption consideration increased 24% when the “Product of the Year” logo is featured in an FSI.
“We are honored that Carmex Cold Sore Treatment was voted as winner in the Specialty Skin Treatment category,” said Jona Mancuso, marketing director at Carma Laboratories. “We are in excellent company and feel that this is a major milestone for the Carmex brand.”
The brand accepted the award yesterday during a special ceremony in New York. Beginning Feb. 12, the distinctive red “Voted Product of the Year” logo will be leveraged across all marketing channels, including product packaging, advertising, promotions and the brand website, www.carmexcoldsore.com.
Carmex Cold Sore Treatment works on contact to block pain and itch while minimizing the appearance of a cold sore. The formulation including 10% Benzocaine blocks pain and itch, while the TriPLEX Formula technology smoothes and fills to make the cold sore less noticeable.
Carmex Cold Sore Treatment has a suggested retail price of $14.99 (0.07 oz. tube).